FAQs: Challenging Host Cell Protein Assays For Improved Risk Mitigation
Source: Cytiva

Andrew Hamilton, PhD, Scientist, Imaging & Western Blotting, and Joe Hirano, PhD, Program Manager, Imaging & Western Blotting, answer top questions about challenging host cell protein assays. Topics covered include: alternate technology, coverage analysis, ELISA antibody, ELISA troubleshooting, ELISA validation, HCP, and regulatory requirements.
access the Q&A!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more